News for Sutro Biopharma, Inc. (STRO)

Published at

Mar 3, 2025 11:00 PM

by gurufocus.com

neutral

neutral

Sutro Biopharma to Present at the TD Cowen 45th Annual Health Care Conference

SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) ( STRO), a clinical-stage oncology company pionee

STRO

Read more →
Published at

Mar 3, 2025 10:13 PM

by manilatimes.net

positive

positive

Sutro Biopharma to Present at the TD Cowen 45th Annual Health Care Conference

**media[556068]**

STRO COWNL COWN

Read more →
Published at

Feb 25, 2025 11:00 PM

by gurufocus.com

positive

positive

Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

-- Completed Successful VAX-31 Phase 2 Adult Program; Company Remains on Track to Initiate VAX-31 Adult Phase 3 Pivotal, Non-Inferiority Study by Mid-2025 and A

STRO PCVX

Read more →
Published at

Feb 25, 2025 10:22 PM

by manilatimes.net

positive

positive

Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

**media[550219]**

STRO PCVX FRGAP COWNL COWN

Read more →
Published at

Feb 12, 2025 11:00 PM

by gurufocus.com

positive

positive

Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

SAN CARLOS, Calif., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. ( PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to

STRO PCVX

Read more →
Published at

Jan 7, 2025 11:00 PM

by gurufocus.com

neutral

neutral

Sutro Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) ( STRO), a clinical-stage oncology company pioneer

STRO

Read more →
Published at

Jan 7, 2025 3:00 PM

by gurufocus.com

neutral

neutral

Sutro Biopharma and Boehringer Ingelheim BioXcellence™ collaboration: Established first-in-class cell-free capabilities at commercial scale

SOUTH SAN FRANCISCO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Boehringer Ingelheim BioXcellenceâ„¢ and Sutro Biopharma Inc.today announced that they successf

STRO

Read more →
Published at

Jan 3, 2025 12:28 AM

by seekingalpha.com

neutral

neutral

Sutro Biopharma: I Don't Buy That Their Pipeline Is Worthless (NASDAQ:STRO)

Sutro Biopharma's valuation remains compelling despite recent market hits, with optimism for a turnaround. Click here to find out STRO stock is a Strong Buy.

STRO

Read more →
Published at

Dec 18, 2024 4:40 PM

by investing.com

neutral

neutral

Sutro Biopharma stock hits 52-week low at $2.02 By Investing.com

Sutro Biopharma stock hits 52-week low at $2.02

STRO

Read more →
Published at

Dec 10, 2024 2:28 PM

by investing.com

negative

negative

Sutro Biopharma Announces Selected Dose for Luvelta and Topline Results from Dose-Optimization Portion of REFRÎ±ME-O1 Trial in Platinum Resistant Ovarian Cancer By Investing.com

Sutro Biopharma Announces Selected Dose for Luvelta and Topline Results from Dose-Optimization Portion of REFRÎ±ME-O1 Trial in Platinum Resistant Ovarian Cancer

STRO MLWEL.PA MLKRI.PA MLAHC.PA

Read more →
Published at

Dec 3, 2024 3:00 PM

by gurufocus.com

positive

positive

Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants

-- Company Expects to Announce VAX-31 Infant Study Topline Safety, Tolerability and Immunogenicity Data from Primary Immunization Series in Mid-2026, Followed b

STRO PCVX

Read more →
Published at

Nov 18, 2024 6:00 PM

by zacks.com

neutral

neutral

Sutro Biopharma (STRO) Upgraded to Buy: Here's What You Should Know

Sutro Biopharma (STRO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

STRO

Read more →
Published at

Nov 13, 2024 11:40 PM

by zacks.com

negative

negative

Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Misses Revenue Estimates

Sutro Biopharma (STRO) delivered earnings and revenue surprises of 20.27% and 53.76%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

STRO

Read more →
Published at

Nov 13, 2024 10:48 PM

by manilatimes.net

mixed

mixed

Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights

**media[465481]**

PCVX STRO FRGAP

Read more →
Published at

Nov 7, 2024 2:00 PM

by rttnews.com

mixed

mixed

Pre-market Movers: APPS, CDLX, XELA, APP, WOLF…

Texas-based Digital Turbine, Inc. (APPS) is down over 38 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

ZG Z.MX Z SEDGN.MX SEDG MTCH1.MX MTCH M1TC34.SA GH.MX GH EPAM.MX EPAM CRSR.MX CRSR CDMOP CDMO BIVI 0L7S.L 0A95.L XELAW XELAU XELA STRO OPFI LYFT.MX LYFT LY0.DE LSF LFST ELF EBS DUO DATS CTVA.MX CTVA CDLX C1TV34.SA APPS APP AMRK 2X0.DE 0LEC.L 0IGA.L 0A6A.L

Read more →
Published at

Nov 7, 2024 11:17 AM

by benzinga.com

mixed

mixed

Why Lyft Shares Are Trading Higher By Over 21%; Here Are 20 Stocks Moving Premarket - Lyft (NASDAQ:LYFT)

Shares of Lyft, Inc. LYFT rose sharply in today's pre-market trading after the company reported better-than-expected quarterly results. Lyft reported quarterly...

STRO MTCH1.MX MTCH MDJH M1TC34.SA LYFT.MX LYFT LY0.DE LSF ENSCW ENSC EBS CAPD.L BUR.L BUR APPS 0IGA.L 0A6A.L SEDGN.MX SEDG CRSR.MX CRSR CDLX APP 0LEC.L 0L7S.L 0A95.L

Read more →
Published at

Sep 26, 2024 12:08 PM

by financialpost.com

mixed

mixed

Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors

SAN MATEO, Calif. —

STRO MRTX FBCL.SN FB.SN DTIL BGNEN.MX BGNE B1GN34.SA AGEN 6160.HK OGN.MX OGN-WI NBIX

Read more →
Published at

May 20, 2024 7:28 PM

by benzinga.com

mixed

mixed

Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Virios Therapeutics (NASDAQ:VIRI)

Loading... Loading... Shares of Virios Therapeutics, Inc. VIRI fell sharply during Monday's session after the company priced a $1.7 million public offering of ...

TYHT TELL TANH SINT REKR NEXTW NEXT IPW IBTX GS2C.DE GME.MX GME DUO DMTKW DMTK.MX DMTK CRKN CNEY CMCM CETXP CETX BYND.CN BNED 0LE3.L 0A8S.L 0A6L.L WIXN.MX WIX STRO PTCT LIAN.MX LI JAGX IGMS CCM AKTS SKIN INO.MX INO HIMS-WT HIMS GTBP DOCS 0A43.L

Read more →
Published at

Apr 6, 2024 12:31 AM

by seekingalpha.com

positive

positive

Ipsen And Sutro Partnering On ADCs Is A Deal Offering Opportunities For Investors (IPSEY)

Ipsen S.A. partners with Sutro Biopharma, Inc. to develop a pre-clinical antibody drug candidate. Read more on IPSEF and STRO stock here.

STRO MRKD.BA MRK.SN MRK.PA MRK.MX MRK JNJ IPSEY IPNN.MX IPN.PA DJNJ3.BA DJNJ2.BA 6MK.DE

Read more →
Published at

Mar 28, 2024 7:08 PM

by benzinga.com

mixed

mixed

Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session - Akanda (NASDAQ:AKAN), Abits Group (NASDAQ:ABTS)

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share.

TNXP SZL.AX SOBR SMMT SEZNL REX OTRKP OTRK OPK.TA OPK.MX OPK NTRB NKLA.MX NKLA NCNA MSTR MARA KTRA GMDA GILDD.BA GILD ELCI34.SA ELAA.DE EL CZOO CC.MX CC AVTX ARECW AREC 8NI.DE 0KCS.L 0JTM.L 0HWG.L 0A7O.L 0A4T.L 0A3R.L XXII UGROD UGRO STRO MTTR KOD DTST CND-WT CND-UN CND ALT 0LHJ.L 0A4C.L CUKPF CUK CCLN.MX CCL1N.MX CCL.L CCL C1CL34.SA 0EV1.L

Read more →